Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure

European Heart Journal

Volumn 35, Issue 48, 2014, Pages 3434-3441

  Vodovar, Nicolas ^a,b   Séronde, Marie France ^a,c   Laribi, Said ^a,d,e   Gayat, Etienne ^a,d,e   Lassus, Johan ^f   Boukef, Riadh ^g   Nouira, Semir ^g   Manivet, Philippe ^a,d   Samuel, Jane Lise ^a,d   Logeart, Damien ^a,b,d,h   Ishihara, Shiro ^a,i   Solal, Alain Cohen ^a,b,d,h   Januzzi, James L ^j   Richards, A Mark ^k,l   Launay, Jean Marie ^a,d   Mebazaa, Alexandre ^a,d,e,h  

^a AP HP Saint Louis and Lariboisière University Hospitals   (France)

^b DHU Fire   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e DHU Neurovasc   (France)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k UNIVERSITY OF OTAGO   (New Zealand)

^l NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

more..

Author keywords

Acute decompensated heart failure; BNP; Furin activity; Glycosylation; NT proBNP; ProBNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CORIN PROTEIN; FURIN; PROTEIN; UNCLASSIFIED DRUG; CORIN PROTEIN, HUMAN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); SERINE PROTEINASE;

ACUTE HEART FAILURE; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; PROTEIN PROCESSING; REGULATORY MECHANISM; ACUTE DISEASE; AGED; BIOSYNTHESIS; BLOOD; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; FEMALE; HEART FAILURE; MALE; METABOLISM;

ACUTE DISEASE; AGED; COHORT STUDIES; DYSPNEA; FEMALE; FURIN; GLYCOSYLATION; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SERINE ENDOPEPTIDASES;

EID: 84911893777     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu314     Document Type: Article

References (26)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847.
2. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147-e239.
3. Seronde MF, Gayat E, Logeart D, Lassus J, Laribi S, Boukef R, Sibellas F, Launay JM, Manivet P, Sadoune M, Nouira S, Solal AC, Mebazaa A. Comparison of the diagnostic and prognostic values of B-Type and atrial-Type natriuretic peptides in acute heart failure. Int J Cardiol 2013; 168: 3404-3411.
4. Savarese G, Trimarco B, Dellegrottaglie S, Prastaro M, Gambardella F, Rengo G, Leosco D, Perrone-Filardi P. Natriuretic peptide-guided therapy in chronic heart failure: a meta-Analysis of 2, 686 patients in 12 randomized trials. PLoS One 2013; 8: e58287.
5. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J Clin Invest 1995; 96: 1280-1287.
6. Semenov AG, Tamm NN, Seferian KR, Postnikov AB, Karpova NS, Serebryanaya DV, Koshkina EV, Krasnoselsky MI, Katrukha AG. Processing of pro-B-Type natriuretic peptide: furin and corin as candidate convertases. Clin Chem 2010; 56: 1166-1176.
7. Tonne JM, Campbell JM, Cataliotti A, Ohmine S, Thatava T, Sakuma T, Macheret F, Huntley BK, Burnett JC Jr, Ikeda Y. Secretion of glycosylated pro-B-Type natriuretic peptide from normal cardiomyocytes. Clin Chem 2011; 57: 864-873.
8. Schellenberger U, O'Rear J, Guzzetta A, Jue RA, Protter AA, Pollitt NS. The precursor to B-Type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 2006; 451: 160-166.
9. Semenov AG, Postnikov AB, Tamm NN, Seferian KR, Karpova NS, Bloshchitsyna MN, Koshkina EV, Krasnoselsky MI, Serebryanaya DV, Katrukha AG. Processing of probrain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem 2009; 55: 489-498.
10. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine functionis an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006; 290: H17-H29.
11. Dong N, Chen S, Yang J, He L, Liu P, Zheng D, Li L, Zhou Y, Ruan C, Plow E, Wu Q. Plasma soluble corin in patients with heart failure. Circ Heart Fail 2010; 3: 207-211.
12. Vidricaire G, Denault JB, Leduc R. Characterization of a secreted form of human furin endoprotease. Biochem Biophys Res Commun 1993; 195: 1011-1018.
13. Giuliani I, Rieunier F, Larue C, Delagneau JF, Granier C, Pau B, Ferriere M, Saussine M, Cristol JP, Dupuy AM, Merigeon E, Merle D, Villard S. Assay for measurement of intact B-Type natriuretic peptide prohormone in blood. Clin Chem 2006; 52: 1054-1061.
14. Andrews GL, Shuford CM, Burnett JC Jr, Hawkridge AM, Muddiman DC. Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 948-954.
15. Wu C, Wu F, Pan J, Morser J, Wu Q. Furin-mediated processing of Pro-C-Type natriuretic peptide. J Biol Chem 2003; 278: 25847-25852.
16. Yan W, Wu F, Morser J, Wu Q. Corin, a transmembrane cardiac serine protease, acts as a pro-Atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci USA2000; 97: 8525-8529.
17. Becker GL, Sielaff F, Than ME, Lindberg I, Routhier S, Day R, Lu Y, Garten W, Steinmetzer T. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. J Med Chem 2010; 53: 1067-1075.
18. Christ-Crain M, Breidthardt T, Stolz D, Zobrist K, Bingisser R, Miedinger D, Leuppi J, Tamm M, Mueller B, Mueller C. Use of B-Type natriuretic peptide in the risk stratification of community-Acquired pneumonia. J Intern Med 2008; 264: 166-176.
19. Jensen J, Ma LP, Fu ML, Svaninger D, Lundberg PA, Hammarsten O. Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio. Clin Res Cardiol 2010; 99: 445-452.
20. Pirracchio R, Deye N, Lukaszewicz AC, Mebazaa A, Cholley B, Mateo J, Megarbane B, Launay JM, Peynet J, Baud F, Payen D. Impaired plasma B-Type natriuretic peptide clearance in human septic shock. Crit Care Med 2008; 36: 2542-2546.
21. Yetkin O, Hacievliyagil SS, Gunen H. Assessment of B-Type natriuretic peptide in patients with pneumonia. Int J Clin Pract 2008; 62: 488-491.
22. Luckenbill KN, Christenson RH, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Tate J, Wu AH, Ler R, Apple FS. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNPand NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 2008; 54: 619-621.
23. Roubille F, Delseny D, Cristol JP, Merle D, Salvetat N, Larue C, Davy JM, Leclercq F, Pasquie JL, Guerrier L, Fareh J, Dupuy AM. Depletion of proBNP1-108 in patients with heart failure prevents cross-reactivity with natriuretic peptides. PLoS One 2013; 8: e75174.
24. Seferian KR, Tamm NN, Semenov AG, Tolstaya AA, Koshkina EV, Krasnoselsky MI, Postnikov AB, Serebryanaya DV, Apple FS, Murakami MM, Katrukha AG. Immunodetection of glycosylated NT-proBNP circulating in human blood. Clin Chem 2008; 54: 866-873.
25. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000; 36: 355-359.
26. Nishikimi T, Ikeda M, Takeda Y, Ishimitsu T, Shibasaki I, Fukuda H, Kinoshita H, Nakagawa Y, Kuwahara K, Nakao K. The effect of glycosylation on plasma N-Terminal proBNP-76 levels in patients with heart or renal failure. Heart 2012; 98: 152-161.